Solas BioVentures Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Solas BioVentures Management LLC
CRD #322344
SEC #801-134738
CIK #
AUM 165.0 M (2026-04-16)
Employees 6 (83% Investors, 0% Brokers)
Phone423-243-3460
Address412 Georgia Avenue
Chattanooga, TN 37403
Source [IAPD] [Website]
Total AUM ($M)
180144108723602010201520212027
Type Form D Funds Date Sold AUM
VC Solas Areteia SPV 2025-10-10 1.8 M
VC Solas Arrivo B Sidecar 2025-10-10 1.8 M
VC Solas Basking Holdings [2025-10-10] 9.0 M 9.0 M
Filed 2024-07-30 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Solas BioVentures Emerging Healthcare Fund LP [2025-10-10] 35.1 M 48.6 M
Filed 2024-05-21 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
VC Solas BioVentures Fund II LP [2025-10-10] 35.1 M 28.7 M
Filed 2022-07-05 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Solas BioVentures Fund I LP 2025-10-10 10.6 M
VC Solas Cryosa Sidecar [2025-10-10] 6.9 M 3.5 M
Filed 2024-07-30 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Solas Francis Sidecar [2025-10-10] 9.0 M 31.0 M
Filed 2024-07-30 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Solas Intershunt Sidecar [2025-10-10] 1.4 M 1.5 M
Filed 2025-01-16 (D) · Exemption 506(b), 3(c), 3(c)(1) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC Solas Maclellan Group JV 2025-10-10 12.3 M
View All
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 12 165.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 12 165.0
By Discretionary
Discretionary 12 165.0
Non-Discretionary 0 0.0
Total 12 165.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 165.0
Total 12 165.0
Form D Directors Role # Filings # Firms 2011 - 2026
David Adair Executive Officer 29 2
Michael Hoey Executive Officer 19 2
David Belitz Executive Officer 14 2
Mark Hackett Executive Officer 14 2
Charles Adair Executive Officer 3 2
Solas BioVentures Management LLC Promoter 9 1
Solas Partners II LLC Promoter 7 1
Solas BioVentures Emerging Healthcare GP LLC Promoter 2 1
Firm Profile (Form ADV)
Discretionary AUM$0.2B
ServesInstitutional
Fund TypesPrivate Equity
Comparable Firms State AUM
Path Capital Partners LLC
FL 169.0 M
Overlay Management LLC
GA 168.6 M
Frontline Healthcare Partners LLC
SC 168.1 M
Norland Capital LP
167.5 M
Wingman Growth Partners LP
CT 167.2 M
Evolution Private Investment Collective LLC
CA 166.5 M
V29 Capital Management LLC
166.1 M
Conifer Infrastructure Management Company LLC
PA 164.8 M
Marquee Capital Advisors LLC
IL 162.7 M
Maple Park Capital Partners Management LP
TX 162.2 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com